Corvus Pharmaceuticals Inc sell me8
Start price
20.09.21
/
0%
€5.55
Target price
20.09.22
€4.00
Performance (%)
-13.87%
End price
30.09.21
€4.78
Summary
This prediction ended on 30.09.21 with a price of €4.78. The prediction for Corvus Pharmaceuticals Inc closed with a convincing performance of -13.87%. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Corvus Pharmaceuticals Inc | 6.646% | 6.646% | 50.615% |
iShares Core DAX® | 2.594% | -1.158% | 14.782% |
iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% |
iShares Nikkei 225® | 0.687% | -8.354% | 18.454% |
iShares S&P 500 | 2.209% | -0.942% | 31.361% |
According to me8 what are the pros and cons of Corvus Pharmaceuticals Inc for the foreseeable future?
Pros
Good culture
Cons
Probably not worthwhile Investment
Below average Management
Little innovation
Comments by me8 for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Sell Corvus Pharmaceuticals Inc
Kursziel gesetzt auf 4,0
In the thread Trading Corvus Pharmaceuticals Inc
Sell beendet